Trulieve Cannabis Corp., a leading U.S. medical cannabis company, announced that its Chief Corporate Affairs and Strategy Officer, Christine Hersey, will participate in a panel discussion at the IgniteIt Cannabis Capital & Policy Summit on November 18, 2026. The discussion will focus on strategies to unlock institutional capital following the company's uplisting. Trulieve operates in multiple states and aims to grow through its hub strategy, offering innovative cannabis products. Investors can find more event details and presentations on the company's investor website.
Trulieve Cannabis Corp.'s November 2026 event participation is presented here with Pluang's Health-sector market data as context. For readers following Health-sector US stocks on Pluang as of Nov 11, 2026 19:11 WIB: out of 150 stocks, 67 rose and 75 fell. Notably, TXG (10X Genomics Inc) rose 3.50% to USD 65.10 with 82% buy orders and a typical hold time of 92 days, while CGC (Canopy Growth Corp) increased 3.31% to USD 0.61 with 100% buy orders and a shorter hold time of 40 days. MDLN (Medline Inc.) declined 2.93% to USD 39.71 with a typical hold time of just 6 days.
Richtech Robotics announced its Intelligent Cleaning System at ISSA Show North America 2026, which integrates autonomous cleaning robots with CCTV cameras to enable proactive, targeted cleaning. This system uses real-time data to optimize cleaning ta...
Blue Gold Limited is reducing operating costs and restructuring its balance sheet to address financial obligations and comply with Nasdaq listing requirements. The company is cutting headcount, streamlining operations, and exploring creditor arrangem...
ZJK Industrial Co., Ltd. has developed a six-series product matrix of precision components tailored for the robotics industry, including gear transmission parts and robotic elastic components. This move aims to meet rising demand driven by advances i...
The Vertex CompOps™ Index 2026 reveals that only 16% of companies regularly address indirect taxes at the board or executive level. Firms that do so report fewer externally detected errors, respond faster to tax authority inquiries, and use AI more e...
NRx Pharmaceuticals has begun selling a new preservative-free ketamine made in the U.S., addressing a shortage that has persisted since 2018. This ketamine uses innovative blow-fill-seal technology, eliminating the preservative benzethonium chloride,...
